Simergent

Simergent will be attending ASN Kidney Week in San Diego, CA Oct 23rd-26th. Contact us if you'd like to meet at the conference. #KidneyWk #peritonealdialysis #dialysis #healthinnovations #PatientSafety

Simergent is excited to announce the publication of "Peritoneal Dialysis (PD) Patient and Nurse Preferences around Novel and Standard Automated PD Device Features" in ASN's peer-reviewed Kidney360 journal. This study was conducted and funded by an independent 3rd party surveying PD cycler feature preferences among current PD patients and PD nurses. It compares the features similar to Simergent's Archimedes device to features similar to existing PD cyclers. Patients preferred Archimedes' features with a 98% preference score, while features similar to other cyclers scored 29% to 36% preference. Read more about the study published in Kidney360 here: https://lnkd.in/gzjVFHPd #peritoneal #dialysis #dialysismarket #peritonealdialysis #kidneyhealth #renalcare #dialysistreatment #nephrology #dialysispatients #dialysistechnology #renalreplacementtherapy

Simergent is delighted to announce our partnership with the Oklahoma Center for the Advancement of Science and Technology (OCAST), a driving force behind innovation and technological-based advancement. Thank you to OCAST's funding and support of Simergent and our innovative home dialysis technologies. Together, we're shaping a brighter future and making a significant impact in Oklahoma. This support was made possible by U.S. Treasury’s State Small Business Credit Initiative (SSBCI) and/or U.S. Treasury's SSBCI funds administered through OCAST’s Industry Innovation Initiative Program (formerly OARS).